Profound Medical Corp.
PRN.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.34M | -28.20M | -31.53M | -27.73M | -28.17M |
| Total Depreciation and Amortization | 840.00K | 927.00K | 797.00K | 861.00K | 896.00K |
| Total Amortization of Deferred Charges | -46.00K | -46.00K | 90.00K | 45.00K | -- |
| Total Other Non-Cash Items | 2.40M | 1.87M | 3.50M | 3.68M | 4.00M |
| Change in Net Operating Assets | 2.51M | 2.57M | 2.57M | 603.00K | 1.96M |
| Cash from Operations | -26.64M | -22.88M | -24.57M | -22.55M | -21.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.15M | -2.49M | -2.17M | -1.69M | -1.26M |
| Issuance of Common Stock | 39.21M | 62.15M | 22.94M | 22.95M | 23.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.04M | -4.90M | -1.86M | -1.86M | -1.86M |
| Cash from Financing | 34.02M | 54.77M | 18.92M | 19.39M | 20.07M |
| Foreign Exchange rate Adjustments | -2.13M | -3.19M | -848.00K | -2.04M | -557.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.25M | 28.70M | -6.50M | -5.20M | -1.80M |